Thirty-day data from a 225-patient trial showed use of Endologix's Ovation abdominal stent graft system led to at least 28% more women becoming eligible for minimally invasive endovascular aneurysm repair. The adverse event rate for the device was 1.3%, with a 3.9% readmission rate and no deaths, limb occlusion or proximal endoleaks.
Data show positive results for Endologix's abdominal stent graft system
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.